Rise and shine. Another day is on the way. And as usual, this promises to be a busy one, especially since we hope to meet with a source or two amid the usual scramble of deadlines. We envision, therefore, a day filled with several cups of stimulation. What better way to ensure productivity, though? We trust you can relate, so hoist a cup and dig in to a few tidbits. Have a great day and keep us in mind if you hear anything interesting...
Could Autism Be Reversed With A Pill? (The Boston Globe)
New Teva CEO Undertakes R&D Review (Ha'aretz)
Roche First-Quarter Sales Hurt By Pricing (Bloomberg News)
Watson May Buy Actavis By End Of April (Reuters)
Gilead Bets On Hepatitis C Data To Justify Pharmasset Deal (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates throughout the day
road pic thx to NicholasT on flickr